Abstracts Archive - Page 1269 of 2607 - ACR Meeting Abstracts

Abstract Number: 1240 • 2018 ACR/ARHP Annual Meeting
Foot Osteomyelitis in Inflammatory Rheumatic Diseases: A Retrospective Observational Study
Alexis HOMS¹, Patrick ABOUKRAT², Christian JORGENSEN^3,4 and Yves-Marie PERS^5,6, ¹Department of rheumatology, Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital, Montpellier, France, ²Department of physical medical rehabilitation, Lapeyronie University Hospital, Montpellier, France., Montpellier, France, ³Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, CHU Lapeyronie., Montpellier, France, ⁴biotherapy, Inserm u1183, Unite ImmunoRhumatologie Therapeutique, Montpellier, France, ⁵Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital Montpellier, MONTPELLIER, France, ⁶INSERM U1183, IRMB, INSERM U1183, Montpellier, France
Background/Purpose: Foot involvement is frequently pointed by patients with chronic inflammatory rheumatic diseases (IRD), such as rheumatoid arthritis (RA), spondyloarthritis (SpA) or psoriatic arthritis (PsA).…
Abstract Number: 1241 • 2018 ACR/ARHP Annual Meeting
Pneumococcal Vaccination Quality Improvement Initiative within a Rheumatology Clinic at an Academic Medical Center
Ali Goodson¹, Bonita Libman², Alana Nevares³, Melinda Edwards² and Amanda Kennedy⁴, ¹Pharmacy, The University of Vermont Medical Center, Burlington, VT, Afghanistan, ²Medicine/Rheumatology, University of Vermont Medical Center, Burlington, VT, ³Rheumatology, University of Vermont Medical Center, Burlington, VT, ⁴Internal Medicine, University of Vermont Medical Center, Burlington, VT
Background/Purpose: Rheumatology patients are at an increased risk of infection secondary to immunosuppressive medications used for disease management. However, vaccination is underutilized and rates remain…
Abstract Number: 1242 • 2018 ACR/ARHP Annual Meeting
Rheumatologists Participating in the RISE Registry Succeeded in the First Year of the Merit-Based Incentive Payment System (MIPS)
Tracy Johansson¹, Ryan Larosa², Rachel Myslinski³, Norlita Brown¹, Lindsay Lewis¹ and Jinoos Yazdany⁴, ¹Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ²American College of Rheumatology, Atlanta, GA, ³Practice, Advocacy, & Quality, American College of Rheumatology, Atlanta, GA, ⁴University of California, San Francisco, San Francisco, CA
Background/Purpose: Under the Medicare Access and CHIP Reauthorization Act (MACRA), rheumatologists face financial repercussions through the Merit-Based Incentive Payment System (MIPS) based on performance on…
Abstract Number: 1243 • 2018 ACR/ARHP Annual Meeting
A Quality Improvement Initiative to Increase Adherence to Hydroxychloroquine Dosing Guidelines at an Academic Medical Center
Ryan Jessee, Stephanie L. Giattino, Atul Kapila, Katherine Kaufman, Jon Golenbiewski, Brian J. Andonian, David Leverenz and Lisa Criscione-Schreiber, Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC
Background/Purpose: In 2016, the American Academy of Ophthalmology published revised guidelines on HCQ dosing, recommending a maximum daily dose of 5mg/kg actual body weight as…
Abstract Number: 1244 • 2018 ACR/ARHP Annual Meeting
Hydroxychloroquine Quality Improvement Project at UF Health Jacksonville Rheumatology Clinics
Shameik Brooks, Gurjit Kaeley and Lanh Dang, UF Health Jacksonville, Jacksonville, FL
Background/Purpose: Hydroxychloroquine (HCQ) is a treatment option for lupus erythematosus and rheumatoid arthritis. The risk of retinopathy in the first 5 years of therapy is…
Abstract Number: 1245 • 2018 ACR/ARHP Annual Meeting
Methotrexate Quality Improvement Project at UF Health Jacksonville Rheumatology Clinics
Shameik Brooks, Gurjit Kaeley and Lanh Dang, UF Health Jacksonville, Jacksonville, FL
Background/Purpose: The diagnosis of interstitial lung disease (ILD) is comprised of a large group of respiratory disorders. ILD can lead to scarring of lung tissue.…
Abstract Number: 1246 • 2018 ACR/ARHP Annual Meeting
Practices of Hydroxychloroquine Dosing Based on the American Association of Ophthalmology (AAO) 2016 Recommendations: A Single Center Experience
Anthony Ocon¹, Muhammad Saad Shaukat², Vivek Mehta³, Mohamed Tageldin¹, David Morales⁴, Ernesto Acosta⁴, Jessica Calderone⁴, Marilyn Humantla⁴ and Ruben Peredo¹, ¹Medicine, Albany Medical Center, Albany, NY, ²Albany Medical Center, Albany, NY, ³Division of Rheumatology, Department of Medicine, Albany Medical College, Albany, NY, ⁴Medicine, Albany Medical College, Albany, NY
Background/Purpose: In March 2016, the AAO updated antimalarial medication screening recommendations for retinopathy prevention, with a recommended dose of hydroxychloroquine (HCQ) ≤5.0 mg/kg total body…
Abstract Number: 1247 • 2018 ACR/ARHP Annual Meeting
Pharmacist-Managed Titration of Urate-Lowering Therapy to Streamline Gout Management
Irvin Huang¹, Jean Liew², Meredith Barnes³, Silu Zuo⁴, Carol Crawford⁴ and Alison Bays⁵, ¹Internal Medicine, Boise VAMC, Boise, ID, ²Internal Medicine; Division of Rheumatology, University of Washington, Seattle, WA, ³Medicine, University of Washington, Seattle, WA, ⁴Harborview Medical Center, Seattle, WA, ⁵Division of Rheumatology, University of Washington, Seattle, CA
Background/Purpose: The treat-to-target approach for serum uric acid is the recommended model in gout management according to the 2012 American College of Rheumatology (ACR) guidelines.…
Abstract Number: 1248 • 2018 ACR/ARHP Annual Meeting
Revisit an Old Question: Should Glucose-6-Phosphate Dehydrogenase Level be Checked in Patients with Rheumatic Diseases Prior to Initiating Certain Drugs?
Irina Abramova¹, Swosty Tuladhar¹, Kyle Park², Carol Hosny³, Erin Taub⁴, Asha Patniak⁵ and Qingping Yao⁶, ¹Rheumatology, Stony Brook University Hospital, Stony Brook, NY, ²Internal Medicine, Stony Brook University Hospital, Stony Brook, NY, ³Medicine, Stony Brook University Hospital, Stony Brook, NY, ⁴Department of Medicine, Stony Brook University Hospital, stony brook, NY, ⁵Stony Brook University Hospital, Stony Brook, NY, ⁶Rheumatology, Allergy and Immunology, Stony Brook University Hospital, Stony Brook, NY
ABSTRACT: Background/Purpose: Glucose 6 Phosphate Dehydrogenase (G6PD) deficiency is the most common enzymatic disorder of red blood cells, and its frequency varies among different ethnicities.…
Abstract Number: 1249 • 2018 ACR/ARHP Annual Meeting
Contraception Compliance in Patients with Rheumatological Diseases on Disease Modifying Antirheumatic and Cytotoxic Drugs
Sara Naji Rad¹, Paris Pacheco², Luis Calvo², Htet Htet Maung², Wajiha Illyas² and Prachi Anand³, ¹Internal Medicine, Nassau University Medical Center, East meadow, NY, ²Internal Medicine, Nassau University Medical Center, East Meadow, NY, ³Chief of Rheumatology, Nassau University Medical Center, East Meadow, NY
Background/Purpose: Women of child bearing age with autoimmune diseases are often prescribed teratogenic medications as Methotrexate, Mycophenolate Mofetil, Leflunomide and Cyclophosphamide. Contraceptive compliance in this…
Abstract Number: 1250 • 2018 ACR/ARHP Annual Meeting
An Evaluation of Utilization Patterns and Appropriateness of Laboratory Tests Among New Referrals to Rheumatologists: Choosing Unwisely!
Sierra Barrett¹, Azin Ahrari¹, Sherry Rohekar², Pari Basharat³ and Janet E. Pope⁴, ¹Schulich School of Medicine and Dentistry, London, ON, Canada, ²Western University, London, ON, Canada, ³St. Joseph's Health Care London, London, ON, Canada, ⁴Department of Medicine, University of Western Ontario, London, ON, Canada
Background/Purpose: Laboratory testing comprises the highest volume procedure in medicine and is therefore an important target for improving healthcare spending and efficiency. Unnecessary testing both…
Abstract Number: 1251 • 2018 ACR/ARHP Annual Meeting
Guideline Adherence for Perioperative Use of Immunosuppressive Medications in Patients with Rheumatologic Disease
Grace Berlin, Carolyn Casey, Susan Kim and James Ross, Rheumatology, Lehigh Valley Health Network, Allentown, PA
Background/Purpose: In response to the lack of clear data to dictate recommendations for use of DMARDs and biologic therapy in the perioperative period, The American…
Abstract Number: 1252 • 2018 ACR/ARHP Annual Meeting
Screening for Tuberculosis before Initiating TNF Inhibitors: How Well Do We Do? a Nationwide Experience
Karim Ladak¹, Ting Pan² and Catherine MacLean¹, ¹Rheumatology, Hospital For Special Surgery, New York, NY, ²Value Office, Hospital For Special Surgery, New York, NY
Background/Purpose: Tumor necrosis factor inhibitors (TNFi) revolutionized treatment of various conditions, however they drastically increase the risk of latent tuberculosis (LTBI) reactivation. Many national medical…
Abstract Number: 1253 • 2018 ACR/ARHP Annual Meeting
Lipid Screening and Treatment Patterns Among Patients with Rheumatic Diseases
Alexander Peck¹, Gilbert Ortega², Jawad Bilal³, Ella Starobinska², Phan Saligrama² and Dominick Sudano⁴, ¹Division of Internal Medicine, University of Arizona College of Medicine, Tucson, AZ, ²Internal Medicine, University of Arizona, Tucson, Tucson, AZ, ³Internal Medicine, University of Arizona, Tucson, AZ, ⁴University of Arizona Arthritis Center, University of Arizona, Tucson, AZ
Background/Purpose: The importance of lipid management is well recognized in rheumatic diseases. In fact, annual cardiovascular risk assessment is especially recommended for individuals with rheumatoid…
Abstract Number: 1254 • 2018 ACR/ARHP Annual Meeting
QI Project: Inpatient Practices in Ordering Fluorescent Anti-Nuclear Antibodies (F-ANA) and ANA Subserologies in a City Hospital in an Underserved Community
Ivan Emil Ramirez de Oleo¹, Beverly Johnson^2,3 and Barbara Mendez-Agrusa⁴, ¹Internal Medicine, Jacobi Medical Center, Bronx, NY, ²Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY, ³Rheumatology, Albert Einstein College of Medicine, Bronx, NY, ⁴Medicine, Department of Rheumatology, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: It is important for internists to know how to appropriately and effectively order subspecialty labs. As part of the choosing wisely campaign in 2013,…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].